CTN Webinar: Relapse Prevention.
CTN Webinar: Relapse Prevention. – This 90-minute webinar, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, explores the issue of relapse among individuals with substance use disorders (SUD). Outcome studies, types and effects of lapse and relapse, and factors contributing to relapse are reviewed. A major emphasis of the webinar is on discussing specific clinical strategies to reduce relapse risk, with a focus on current empirical and clinical literature, including findings from quality improvement studies and clinical trials conducted in a drug treatment clinic. The target audience is CTN members and other researchers and clinicians interested in learning more about relapse prevention. Presented by Dennis Daley, PhD, LSW (Western Psychiatric Institute and Clinic, AT Node) and Dennis M. Donovan, PhD (Alcohol & Drug Abuse Institute, University of Washington, PN Node). For more resources related to this webinar, as well as other webinars in this series, visit: ctndisseminationlibrary.org
Key Votes Used to Calculate the Ratings
Filed under: drug abuse treatment outcome study
The Congressional Record roll-call number is followed by the bill number, a description of the vote, the date, the outcome, the prevailing side—conservative (C) or liberal (L)—and the weight given to each (from 1 for the lowest weight to 3 for the …
Read more on National Journal
Aeterna Zentaris: First Patient Treated for Phase 2 Trial with AEZS-108 in …
Filed under: drug abuse treatment outcome study
Juergen Engel, Ph.D., President and CEO of Aeterna Zentaris stated, "Patients with triple-negative breast cancer have poorer outcomes compared to other breast cancer subtypes and are in need of a safe and effective therapeutic regimen. … AEZS-108 is …
Read more on Sacramento Bee
Motivating patients to make wise choices
Filed under: drug abuse treatment outcome study
And research shows that the method, first developed in the 1980s by psychologists to counsel patients with substance abuse problems, has promise for application in treating other medical conditions. A March 17, 2010, Cochrane Collaboration systematic …
Read more on American Medical News